IVF\ICSI Outcome in Women With Polycystic Ovary Syndrome
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age20-35
SponsorEgymedicalpedia
About this trial
Polycystic ovarian syndrome (PCOS) occurs in 5% to 10% of all women of reproductive age and 50% of women who present with sub-fertility due to anovulatory infertility . Clear diagnostic criteria for this condition were identified at the consensus meeting of the European Society of Human Reproduction and Embryology and the American Society for Reproductive Medicine .
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Oligo-ovulation or anovulation.
Clinical and/or biochemical hyper androgenesim.
Polycystic ovaries.
Disqualifiers
Androgen-secreting tumors (ovarian or adrenal).
Adult-onset congenital adrenal hyperplasia.
Thyroid diseases.
Cushing's syndrome.
Trial design
Design model
Parallel
Treatments tested in this trial
the pregnancy rate at IVF / ICSI cycles
Procedure/SurgeryTo study and compare other parameters between the PCOS and non PCOS group, and inside the PCOS group itself eg ; patients with PCOS who have ovarian drilling and non drilling PCOS
Treatment groups
156 Participants
are divided into 2 treatment groupsGroup A: PCOs PatientsActive comparator 1 intervention
Group B: Non PCOs PatientsActive comparator 1 intervention
Trial outcomes
Primary outcomes
1
pregnancy rate
To compare the pregnancy rate at IVF / ICSI cycles between women with PCOS and non PCOS women
Time frame
From baseline to 15 days after the embryo transfere day.Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov